Health Bulletin Haiti: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Bulletin Haiti.

Press releases published on May 11, 2026

28 minutes ago

Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up

Indeterminate GlobeNewswire

32 minutes ago

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

Indeterminate GlobeNewswire

33 minutes ago

4basebio Launches Enzymatic ssDNA Platform

Indeterminate GlobeNewswire

33 minutes ago

Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

33 minutes ago

Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes

Indeterminate GlobeNewswire

33 minutes ago

Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago

Indeterminate GlobeNewswire

33 minutes ago

Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program

Indeterminate GlobeNewswire

33 minutes ago

Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Observed - Conference Call Scheduled for 8:30am ET

Indeterminate GlobeNewswire

33 minutes ago

Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China

Indeterminate GlobeNewswire

33 minutes ago

Rezolute to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

33 minutes ago

MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing

Indeterminate GlobeNewswire

33 minutes ago

Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

33 minutes ago

Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update

Indeterminate GlobeNewswire

33 minutes ago

Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab)

Indeterminate GlobeNewswire

33 minutes ago

Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

Indeterminate GlobeNewswire

an hour ago

New data shows 5x growth in medical crowdfunding across Europe

Indeterminate GlobeNewswire

an hour ago

Certara Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility

Indeterminate GlobeNewswire

4 hours ago

ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

Indeterminate GlobeNewswire

4 hours ago

Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio

Indeterminate GlobeNewswire